Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

May 23, 2022

Novartis’ Cosentyx gets CHMP positive opinion for use in childhood arthritic conditions

Novartis has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Cosentyx (secukinumab) for usage either alone or in combination with methotrexate.

Novartis’ Cosentyx gets CHMP positive opinion for use in childhood arthritic conditions